Irene Jaffe's Contact Details

Irene Jaffe's Company Details

DermaFlow

Cherry Hill, New Jersey, United States • 2 Employees
Medical Devices

DermaFlow has developed a non-invasive proprietary and patented technology that accurately and cost effectively measures directly peripheral (in the capillaries) blood flow and detects tell-tale changes in microcirculation. It has been estimated that ~ 90% of disease results in microcirculation changes, and therefore having a "friendly"​ and affordable way to monitor this routinely is of significant value to modern healthcare.This technology lends itself easily and expediently to three major healthcare trends:*stream-lined 510 K predicate regulatory track designated (for a stand-alone device)* wireless monitoring for home and remote situations* integration into existing monitoring and/or sensing devicesDermaFlow has completed early proof-of-concept clinical studies, and is focusing currently on acute care (sepsis in ICU patients) with its first stand alone product Perichek Multi.In addition, Dermaflow has completed development of Perichek - a module suitable for integration into established patient monitoring suites.Dermaflow technology has a wide range of applications in acute and chronic care, both in and out of hospital.We welcome interested corporate, clinical, and strategic partners as well as accredited investors.